Colposcopes Market: Cervical Cancer Support

The rise in the organizations, associations, and institutes initiatives for raising the awareness regarding the Cervical Cancer Prevention and Control shall have a positive impact on the market. For instance, 7 UN agencies under the United Nations Task Force on NCDs have established a new 5-year Joint Programmed to prevent and control Cervical Cancer. It aims at providing the diagnosis and treatment of invasive cervical cancer to all women, screening and treatment for cervical pre-cancer available for women, and Human papilloma virus immunization for girls.

Several organizations, associations, and institutes are entering into the collaboration with the companies for the development of colposcopes. In 2017, the Duke University had entered into the collaboration with 3rd Stone Design, Inc for the development of a beta prototype of the Pocket Colposcope. It is a less expensive, smaller in size and lighter than traditional clinical colposcope devices. The growing number of favorable guidelines for cervical screening are expected to fuel the adoption of colposcopes.

To combat this global burden, public organizations like the CDC, WHO, American Cancer Society, and International Agency for Research on Cancer have collaborated with global vendors to improve cervical cancer screening programs globally. 

In countries like Bolivia, Brazil, Colombia, India, Kenya, Thailand, Trinidad, Tobago, and Vietnam, CDC is strengthening the national level cervical cancer screening, either by providing support or by conducting education and training programs. In countries like India, organizations like the Population Services International (PSI) have launched cervical cancer prevention programs to reduce the country’s cervical cancer burden. In these emerging economies, low-cost alternatives like cervical cancer screening through VIA, visual inspection with Lugol’s iodine (VILI), and colposcopy is gradually gaining popularity. This increased awareness, coupled with the initiatives by public organizations, will positively impact the global colposcopes market.

In developed countries, increasing patient pool of cervical cancer and growing need for accurate cervical cancer diagnosis procedures has created vast opportunities for colposcopes market.

Innovation in development of new colposcopes help to create several new market opportunities for the manufacturers.

In addition, well-developed infrastructure capabilities, adoption of video colposcopes, and long-term contracts with end-users is expected to increase the growth rate over the forecast period. Increasing awareness program of various NGO for diagnosis and the treatment of cervical cancer and major manufacturers are the continuous launch of diagnostic equipment for the detection of cancer is estimated to create a new opportunity for the global colposcopes market. In emerging countries, increase in public and private investments in modernizing and improving the healthcare infrastructure has created several opportunities for colposcopes market. Also, rising government initiatives toward better women’s health, business expansion activities of vendors in emerging countries such as Brazil, China, and India are likely to create opportunities over the forecast period.

Conventional colposcopes cannot detect smaller, high-grade lesions present in individuals with poor cytology results. Therefore, the vendors have focused on developing advanced colposcopes to address this challenge. This has paved the way for the shift from optical colposcopes to digital video scopes. DYSIS Medical's DYSIS Colposcope has many benefits such as the ability to measure cervical epithelium and map the cervical condition. 

Also, it assists the clinicians with the process of evaluating the cervix and selecting the biopsy sites if required. The guidelines also stated that DySIS colposcopy has a higher sensitivity that conventional colposcopy. For instance, new colposcopes can detect high-grade lesions with 88% sensitivity, compared to 55% in conventional colposcopy. Recently in February 2016, Bovie Medical Corporation launched a new Colpo-Master line, which offers excellent, 3D stereoscopic viewing with improved clarity during gynecologic procedures. Such advances will drive the adoption of colposcopes worldwide.

Tencent Holdings Limited launched an AI-supported auxiliary diagnostic system for conducting digital colposcopy at the Global Digital Ecosystem Summit being held in Kunming, China. This latest technology can rapidly identify the cervical transformation zone and the location of a lesion, enabling doctors to more accurately and efficiently diagnose cervical cancer – the most common cause of malignant tumors in the female reproductive organs. Tencent is exploring ways to provide the medical industry with targeted solutions and is spearheading the use of new technologies in the sector.

About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com